The FINANCIAL -- WHITEHOUSE STATION, N.J., Sept. 13, 2011 – Merck, known as MSD outside the United States and Canada, announced today that it is contributing $3 million over three years to the Pink Ribbon-Red Ribbon initiative to help address both cervical and breast cancer in sub-Saharan African nations by supporting disease education, screening and treatment efforts as well as increased access to cervical cancer vaccination.

The FINANCIAL -- McKesson today announced McKesson Practice Choice™, a fully integrated electronic health record (EHR) and practice management solution that puts advanced yet easy-to-use technology within reach of small independent primary care practices.

The FINANCIAL -- Today, the U.S. Food and Drug Administration announced organizational changes within the office responsible for reviewing all drug and biologic applications for cancer therapies.

The FINANCIAL -- Berlin, September 13, 2011 – Bayer HealthCare Pharmaceuticals announced today that the company will present new data on several of its investigational compounds at the 2011 European Multidisciplinary Cancer Congress (ECCO-ESMO), September 23-27, 2011, in Stockholm, Sweden.

The FINANCIAL -- Paris, France – September 12, 2011 – Sanofi announced today data that demonstrates that initiating Lantus® (insulin glargine [rDNA origin] injection) in type 2 diabetes patients leads to better glycemic control and comparable and modest weight gain versus a comparator group consisting of other insulins, oral antidiabetics (OADs) and dietary changes.